These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. [Value of nifedipine in respiratory failure related to obstructive chronic bronchitis during treatment over 6 months]. Meurice JC, Boutaud P, Herpin D, Ingrand P, Boita F, Underner M, Patte F. Ann Cardiol Angeiol (Paris); 1989 Mar; 38(3):171-7. PubMed ID: 2735732 [Abstract] [Full Text] [Related]
26. Nifedipine inhibits hypoxic pulmonary vasoconstriction during rest and exercise in patients with chronic obstructive pulmonary disease. A controlled double-blind study. Kennedy TP, Michael JR, Huang CK, Kallman CH, Zahka K, Schlott W, Summer W. Am Rev Respir Dis; 1984 Apr; 129(4):544-51. PubMed ID: 6711997 [Abstract] [Full Text] [Related]
27. Hemodynamic effects of felodipine at rest and during exercise in exertional angina pectoris. Detry JM, De Coster PM, Renkin J. Am J Cardiol; 1983 Sep 01; 52(5):453-7. PubMed ID: 6613867 [Abstract] [Full Text] [Related]
28. Effects of hydralazine on hemodynamics, ventilation, and gas exchange in patients with chronic obstructive pulmonary disease and pulmonary hypertension. Keller CA, Shepard JW, Chun DS, Dolan GF, Vasquez P, Minh VD. Am Rev Respir Dis; 1984 Oct 01; 130(4):606-11. PubMed ID: 6486560 [Abstract] [Full Text] [Related]
30. A comparison of two long-acting vasoselective calcium antagonists in pulmonary hypertension secondary to COPD. Sajkov D, Wang T, Frith PA, Bune AJ, Alpers JA, McEvoy RD. Chest; 1997 Jun 01; 111(6):1622-30. PubMed ID: 9187185 [Abstract] [Full Text] [Related]
32. Differential therapy with calcium antagonists in pulmonary hypertension secondary to COPD. Hemodynamic effects of nifedipine, diltiazem, and verapamil. Gassner A, Sommer G, Fridrich L, Magometschnigg D, Priol A. Chest; 1990 Oct 01; 98(4):829-34. PubMed ID: 2209138 [Abstract] [Full Text] [Related]
34. [Hemodynamic effects of the new calcium antagonist nimodipine in normal and increased blood pressure]. Engberding R, Bender F, Gülker H, Specker E, Molinski M. Z Kardiol; 1984 Aug 01; 73(8):498-503. PubMed ID: 6495809 [Abstract] [Full Text] [Related]
35. [Effects of tetrandrine on pulmonary hypertension in patients with chronic obstructive pulmonary disease]. Kang J. Zhonghua Jie He He Hu Xi Za Zhi; 1993 Feb 01; 16(2):93-4, 124. PubMed ID: 8221961 [Abstract] [Full Text] [Related]
37. Haemodynamic effects of ketanserin either alone or with oxygen in COPD patients with secondary pulmonary hypertension. Domenighetti G, Leuenberger P, Feihl F. Monaldi Arch Chest Dis; 1997 Oct 01; 52(5):429-33. PubMed ID: 9510660 [Abstract] [Full Text] [Related]